Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 Radioembolization for the Treatment of Colorectal Liver Metastases (SIM Trial)

NCT02208804 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT02208804
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02208804 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Surefire Infusion System vs. Standard Microcatheter Use During Holmium-166 Radioembolization for the Treatment of Colorectal Liver Metastases (SIM Trial)
Lead sponsor
UMC Utrecht
Phase
Phase 2/3
Overall status
Unknown status
Start date
November 30, 2014
Completion date
Not reported
Enrollment
25 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal neoplasms, digestive system neoplasms, liver diseases, neoplasm metastasis